|
|
Volumn 10, Issue 9, 2013, Pages 511-512
|
|
IBD: Golimumab in ulcerative colitis: a 'ménage à trois' of drugs.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GOLIMUMAB;
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
ANTAGONISTS AND INHIBITORS;
COLITIS, ULCERATIVE;
HUMAN;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL;
COLITIS, ULCERATIVE;
HUMANS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 84899036281
PISSN: None
EISSN: 17595053
Source Type: Journal
DOI: 10.1038/nrgastro.2013.142 Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|
